2022年肺功能更新与GLI全球参考方程在间质性肺疾病患者中的意义
该研究基于澳大利亚与新加坡间质性肺疾病(ILD)注册队列的2219例成人患者,比较GLI参考方程与欧洲煤钢共同体及Miller参考方程对肺功能百分预计值、ILD风险预测模型及临床试验入组资格的影响。结果显示应用GLI方程后FVC百分预计值平均降低8.8%,DLCO百分预计值平均升高4.9%,风险预测模型对死亡率的预测效能相似,但符合尼达尼布临床试验资格的患者减少。
要点
- 应用GLI参考方程使ILD患者FVC百分预计值平均降低8.8%,DLCO百分预计值平均升高4.9%。
- GLI方程不影响ILD风险预测模型对死亡率的预测效能。
- 应用GLI方程后符合尼达尼布临床试验资格的患者减少(IPF减少19例,非IPF减少119例)。
核心结论
- 在ILD患者中应用GLI参考方程导致DLCO百分预计值升高、肺容积百分预计值降低。
- 应用GLI参考方程不影响预后判断,但符合抗纤维化药物临床试验标准的患者减少。
研究设计与样本
- 研究纳入来自澳大利亚ILD注册队列和新加坡国家医疗集团ILD注册队列的2219例基线有FVC的成人ILD患者。
- 比较欧洲煤钢共同体及Miller参考方程与GLI参考方程对肺功能百分预计值、ILD风险预测模型及临床试验入组资格的影响。
主要发现
- 2219例ILD患者中1712例(77.2%)为白人,以IPF、结缔组织病相关ILD和不可分类ILD为主。
- 中位FVC为2.60(2.01-3.36)L,FEV1为2.09(1.67-2.66)L,DLCO为13.60(10.16-17.60)mL/min/mm Hg。
- 应用GLI参考方程后,平均FVC百分预计值降低8.8%(87.7% vs 78.9%,p<0.01),平均DLCO百分预计值升高4.9%(58.5% vs 63.4%,p<0.01)。
- 应用GLI参考方程后,符合尼达尼布临床试验资格的IPF患者减少19例,非IPF患者减少119例。
- 两种参考方程下的风险预测模型对死亡率的预测效能相似。
临床怎么用
- 在ILD患者肺功能评估中需注意GLI参考方程会系统性改变FVC和DLCO百分预计值,可能影响临床试验筛选。
局限性
- 研究队列以白人为主(77.2%),结果外推至其他种族人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the Global Lung function Initiative (GLI) reference equations and the updated interpretation strategies remain uncertain. METHODS: Adult patients with ILD with baseline forced vital capacity (FVC) were included from the Australasian ILD registry and the National Healthcare Group ILD registry, Singapore.The European Coal and Steel Community and Miller reference equations were compared with the GLI reference equations to assess (a) differences in lung function percent predicted values; (b) ILD risk prediction models and (c) eligibility for ILD clinical trial enrolment. RESULTS: Among 2219 patients with ILD, 1712 (77.2%) were white individuals. Idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD and unclassifiable ILD predominated.Median FVC was 2.60 (2.01-3.36) L, forced expiratory volume in 1 s was 2.09 (1.67-2.66) L and diffusing capacity of the lungs for carbon monoxide (DLCO) was 13.60 (10.16-17.60) mL/min/mm Hg. When applying the GLI reference equations, the mean FVC percentage predicted was 8.8% lower (87.7% vs 78.9%, p<0.01) while the mean DLCO percentage predicted was 4.9% higher (58.5% vs 63.4%, p<0.01). There was a decrease in 19 IPF and 119 non-IPF patients who qualified for the nintedanib clinical trials when the GLI reference equations were applied. Risk prediction models performed similarly in predicting mortality using both reference equations. CONCLUSION: Applying the GLI reference equations in patients with ILD leads to higher DLCO percentage predicted values and smaller lung volume percentage predicted values. While applying the GLI reference equations did not impact on prognostication, fewer patients met the clinical trial criteria for antifibrotic agents.
引用
- Li A, Teoh A, Troy L, et al. Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease. Thorax. 2024. PMID: 39317451. doi:10.1136/thorax-2024-221813
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。